搜索临床试验以:bevacizumab erlotinib hydrochloride
总计10045个结果
-
M.D. Anderson Cancer Center撤销转移性肺非小细胞癌 | IVA 期肺癌 AJCC v8 | IVB 期肺癌 AJCC v8 | IV 期肺癌 AJCC v8
-
Hunan Province Tumor Hospital尚未招聘
-
Hunan Province Tumor Hospital尚未招聘
-
Asan Medical CenterKorean Cancer Study Group; Boryung Pharmaceutical Co., Ltd招聘中
-
Duke UniversityGenentech, Inc.完全的
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Northwestern UniversityM.D. Anderson Cancer Center完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Medical University of South Carolina完全的
-
GERCOR - Multidisciplinary Oncology Cooperative...完全的
-
National Cancer Center, KoreaRoche Korea co.,Ltd.主动,不招人
-
Swiss Group for Clinical Cancer Research完全的
-
University of California, San Francisco完全的
-
Herbert Hurwitz, MDNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and... 和其他合作者完全的
-
Indiana University School of MedicineGenentech, Inc.完全的
-
Peking Union Medical College Hospital招聘中
-
Sun Yat-sen UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
First People's Hospital of HangzhouChia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
National Cancer Institute (NCI)完全的
-
Hoffmann-La Roche完全的
-
Lund University HospitalHoffmann-La Roche完全的
-
First Hospital of Shijiazhuang City未知
-
Fox Chase Cancer CenterGenentech, Inc.; OSI Pharmaceuticals完全的
-
Genentech, Inc.完全的非小细胞肺癌美国, 西班牙, 阿根廷, 以色列, 香港, 泰国, 澳大利亚, 比利时, 巴西, 保加利亚, 意大利, 墨西哥, 菲律宾, 罗马尼亚, 新加坡, 台湾, 英国
-
National Cancer Institute (NCI)完全的
-
Swiss Group for Clinical Cancer Research完全的
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.终止
-
Peking University Third Hospital尚未招聘
-
Peking Union Medical College Hospital招聘中